Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 18/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MTOR | P42345 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7866781 | 0.85 | ALDH1A1 (0.53) | HPGDNPC1ALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL3752723 | 0.83 | PIK3CA (0.69) | PIK3CA | |
| SCHEMBL3750545 | 0.83 | PIK3CA (0.72) | PIK3CA | |
| SCHEMBL3749014 | 0.83 | PIK3CA (0.55) | PIK3CAHPGDNPC1ALDH1A1TP53 | |
| SCHEMBL3756798 | 0.81 | PIK3CA (0.77) | PIK3CAMTOR | |
| SCHEMBL3754202 | 0.80 | PIK3CA (0.83) | PIK3CAMTOR | |
| SCHEMBL3751121 | 0.80 | PIK3CA (0.82) | PIK3CAMTOR | |
| SCHEMBL3761157 | 0.78 | PIK3CA (0.72) | PIK3CAHPGDNPC1ALDH1A1TP53 | |
| SCHEMBL3755611 | 0.74 | PIK3CA (0.75) | PIK3CAMTOR | |
| SCHEMBL3747300 | 0.74 | PIK3CA (0.65) | PIK3CAHPGDNPC1ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100305093-A1 | Inhibitors of mTOR and Methods of Making and Using | EXELIXIS, INC. (US) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305093-A1 | Inhibitors of mTOR and Methods of Making and Using | MTOR, RICTOR, RPTOR | PIK3CA 16/4885HPGD 1748/4885NPC1 181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.